Surrey Heartlands

Joint Formulary & PAD

Naloxone hydrochloride - Opioid overdose

You are here : Home > Formulary Search > Naloxone hydrochloride - Opioid overdose

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous injection (IV)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Please check TOXBASE for further information. https://www.toxbase.org/ . Intramuscular and intranasal preparations are available for use in non-medical settings

 

Status 2

Red
Formulations :
  • Nasal spray
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

May be given intranasally in non-medical settings. See Healthy Surrey website for details on accessing naloxone nasal spray in the community https://www.healthysurrey.org.uk/drugs-and-alcohol/naloxone

 

Status 3

Red
Formulations :
  • Intramuscular injection (IM)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

https://www.toxbase.org/ . May be given by intramuscular injection in non-medical settings.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Naloxone hydrochloride
Indication :
Opioid overdose
Group Name :
Keywords :
opioid reversal, opioid antidote, opioid poisoning, toxbase, CNS depression, community PGD
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Naloxone hydrochloride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Opioid overdose.

  • No records returned.

Committee Recommendations (1)

11 Feb 25 - Surrey Heartlands Medicines Optimisation Board (MOB)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.